Dr. Sangu Komal Govind

ASSISTANT PROFESSOR · PHARMACEUTICAL CHEMISTRY

Author

{# wisp 2026-10-03: share widget — owner only. Links printed in a paper are shared by the person whose profile it is, not by every passerby. #}

APID: 6651
ORCID: 0000-0003-3419-132X
Scopus: 57218667887
Google Scholar: crqeOSEAAAAJ
Location: NAVI MUMBAI, Maharashtra, India
Expertise: MEDICINAL CHEMISTRY, PHARMACEUTICAL CHEMISTRY
Areas of interest: MEDICINAL CHEMISTRY, PHARMACEUTICAL CHEMISTRY
Member since: May 2024

Biography

Researcher and academician with expertise in Medicinal chemistry, Pharmaceutical Chemistry, Drug discovery and development, Synthetic organic chemistry

Publications

Kaul. G., Akhir. A., Shukla. M., Komal G. Sangu., Haridas B. Rode and Siddharth Chopra., Nitazoxanide potentiates linezolid against linezolid-resistant Staphylococcus aureus in vitro and in vivo. J. Antimicrob. Chemother. 2022, 77, 2456-2460.
Komal G. Sangu., Akash U. Shinde, Siddharth Chopra, Haridas B. Rode., Evading Antimicrobial Resistance using Boron containing therapeutics. Fut. Med. Chem. 2020, 13, 229-232.
Komal G. Sangu, Naveen Kotla, Dr. T. D. Neelima. Oxidative dearomatization strategy for facile metal-free synthesisof vanillyl benzodiazepines. chemistrySelect, 2020.
Komal G. Sangu, Saiprasad D. varakala, Vamshi Krishna E, Haridas B. Rode., Synthesis and evaluation of GR135486X derivatives as potent antibacterial agents against Mycobacterium tuberculosis ChemistrySelect. 2023, 8, e202204186.
Oluyori. A.P., Harini. T., Komal G. Sangu., Krishna. E.V., Jadav. S.S., Misra. S. and Rode, H.B., 2022. Synthesis and evaluation of novel almazole D analogs as anticancer agents. Arch. Pharm. 2022, 355, 2200102.
Uttam B. Karale, Dattatraya Babar, Akash U. Shinde, Komal G. Sangu, Siva Krishna V, Vamshi Krishna E, Haridas B. Rode., 3- Aryl substituted imidazo[1,2-a]pyridines as antituberculosis agents. Arch. Pharm. 2021, 354, 2000419.